P160 LONG-TERM PROPHYLAXIS WITH SUBCUTANEOUS C1-INHIBITOR IN US PATIENTS WITH HEREDITARY ANGIOEDEMA AND VERY FREQUENT ATTACKS.

MLA

Craig, T., et al. “P160 Long-Term Prophylaxis with Subcutaneous C1-Inhibitor in Us Patients with Hereditary Angioedema and Very Frequent Attacks.” Annals of Allergy, Asthma & Immunology, vol. 123, Nov. 2019, p. S31. EBSCOhost, https://doi.org/10.1016/j.anai.2019.08.264.

APA

Craig, T., Zuraw, B., Cicardi, M., Longhurst, H., Feuersenger, H., Prusty, S., & Jacobs, I. (2019). P160 Long-Term Prophylaxis with Subcutaneous C1-Inhibitor in Us Patients with Hereditary Angioedema and Very Frequent Attacks. Annals of Allergy, Asthma & Immunology, 123, S31. https://doi.org/10.1016/j.anai.2019.08.264

Chicago

Craig, T., B. Zuraw, M. Cicardi, H. Longhurst, H. Feuersenger, S. Prusty, and I. Jacobs. 2019. “P160 Long-Term Prophylaxis with Subcutaneous C1-Inhibitor in Us Patients with Hereditary Angioedema and Very Frequent Attacks.” Annals of Allergy, Asthma & Immunology 123 (November): S31. doi:10.1016/j.anai.2019.08.264.